Samantha Du is Founding Managing Director of Quan Capital. During her career, she has been a successful drug developer, entrepreneur, and investor.
Dr. Du joined Pfizer in the US in 1994, where she was involved in the development of multiple early and late-stage products, two of which received US FDA approval. She also led the scientific side of Pfizer’s global metabolic licensing group. Dr. Du co-founded Hutchison MediPharma (HMP) and Hutchison China MediTech (Chi-Med, now HUTCHMED) where she served as Chief Executive Officer and Chief Scientific Officer, respectively. She then joined Sequoia Capital China in 2012 as a Managing Director responsible for several healthcare investments.
Dr. Du founded Zai Lab in 2014 to address the unmet medical needs for patients globally.
Due to her outstanding achievements, Dr. Du has been recognized with many global awards, such as honors from FierceBiotech, Forbes, etc. Dr. Du earned her PhD in Biochemistry from the University of Cincinnati.